GGrantIndex
Sort

51,593 grants matching hepatitis

Multimode Observation of Virus Capsid Assembly

$493,431
Adam Zlotnick · Trustees Of Indiana University · R01 · FY2025 · AI

Multimode Observation of Virus Capsid Assembly

$493,431
Adam Zlotnick · Trustees Of Indiana University · R01 · FY2023 · AI

Multimode Observation of Virus Capsid Assembly

$493,431
Adam Zlotnick · Trustees Of Indiana University · R01 · FY2024 · AI

Evaluation of HCC Response to Systemic Therapy with Quantitative MRI

$493,413
Bachir Taouli · Icahn School Of Medicine At Mount Sinai · U01 · FY2014 · CA

Brief Intervention to Reduce STDs in ER Drug Users

$493,390
Boston Medical Center · R01 · FY2004 · DA

Microbial regulation of host nutrient metabolism

$493,345
John F Rawls · Duke University · R01 · FY2015 · DK

Significance of UBIAD1 in Regulation of HMG CoA Reductase Degradation, Mevalonate Metabolism, and Menaquinone-4 Synthesis

$493,341
Russell Alfred Debose-Boyd · Ut Southwestern Medical Center · R01 · FY2021 · GM

Alcohol and Multisubstance Use in the Veterans Aging Cohort Study

$493,340
Amy Caroline Justice · Yale University · U01 · FY2014 · AA

CNS defects in a murine Zellweger syndrome model

$493,293
Columbia University Health Sciences · R01 · FY2004 · NS

Yale Drug Abuse, Addiction, and HIV Research Scholars (Yale-DAHRS)

$493,234
Gail D'onofrio · Yale University · K12 · FY2017 · DA

Metagenomic detection of emerging viruses in the blood supply

$493,106
Eric L. Delwart · Vitalant · R01 · FY2012 · HL

RESEARCH TRAINING CORE

$493,103
Robert Anders · University Of Texas El Paso · P20 · FY2009 · MD

Epigenetic Regulation of Mitochondrial Homeostasis and Energy Metabolism

$493,084
Qin Yang · University Of California-Irvine · R01 · FY2025 · DK

Clinical Core

$493,075
Cornelia L Dekker · Stanford University · U19 · FY2015 · AI

Hepatic Lipotoxicity, Metabolic Homeostasis and NAFLD Pathogenesis

$493,050
Anna Mae Elizabeth Diehl · Duke University · R56 · FY2023 · DK

Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma

$493,027
Sarah A Holstein · University Of Nebraska Medical Center · R01 · FY2023 · CA

Gene Silencing as an Antiviral Defense in Animal Cells

$493,017
Shou-Wei Ding · University Of California Riverside · R01 · FY2016 · AI

Improved Mimotope Structures and Scaffolds for Prime-Boost Strategies

$492,945
David Davis · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2010 · AI

Gene Silencing as an Antiviral Defense in Animal Cells

$492,942
Shou-Wei Ding · University Of California Riverside · R01 · FY2011 · AI

Deconstructing Inflammation and Altered Microbiota in Metabolic Syndrome

$492,910
Andrew T Gewirtz · Georgia State University · R01 · FY2018 · DK

Hepatic steatosis promotes liver metastasis

$492,873
Steven L Teitelbaum · Washington University · R01 · FY2024 · CA

Genetic Risk Stratification to Identify Individuals for Early Statin Therapy

$492,835
Marc S Sabatine · Brigham And Women'S Hospital · RC1 · FY2010 · HL

Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma

$492,732
Sarah A Holstein · University Of Nebraska Medical Center · R01 · FY2022 · CA

Intervention to Reduce Injection Drug Use

$492,670
Robert E Booth · University Of Colorado Denver · R01 · FY2011 · DA

Metabolic heterogeneity underlying hypertriglyceridemia in insulin resistance

$492,664
Daniel Vatner · Yale University · R01 · FY2020 · DK